HCC's Hematological Malignancies Program provides comprehensive evaluation and management of a broad range of blood and lymphatic diseases. Sophisticated radiation oncology, immunotherapy, and stem cell transplantation are incorporated into treatment when appropriate. Our extensive menu of clinical trials for hematological malignancies guarantees all patients access to cutting edge therapy. Highlights include: - Nationally recognized for treatment of acute myeloid leukemia (AML) in adults.
- Research and treatment program tailored for older adults (over 60 years old) with AML.
- Comprehensive management for lymphomas and myeloma, including stem cell transplantation where appropriate.
Active clinical trials: Acute Leukemias: 15; Lymphomas: 4; Others: 4
Experience and innovation have resulted in outcomes that are among the best in the country. Our approach to treating hematological malignancies has made HCC a vital resource for our state. Our Services and Technology Multidisciplinary Team Members Clinical Trials
Patients have access to clinical trials for promising new therapies. The goal of these research efforts is to bring effective new treatments to patients as quickly as possible. Some are designed to improve transplant techniques, while others focus on extending the application of blood and marrow transplants to a wider population of patients.
Read more about clinical trials. More about Hematological Malignancies
Our Cancer Center Health Library explains terminology and treatment options. Learn more about hematological malignancies. Blood and Bone Marrow Transplant Program Support Services for Patients and Family
| 
